Oliver Engert
Known title: Chief Administrative OfficerCIK: 0002105870
Oliver Engert's purchase track record
Oliver Engert has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/2/2026 | ENOV | $200K | pending | pending | — |
| 6/10/2026 | ENOV | $70K | -13.4% | pending | — |
| 6/1/2026 | ENOV | $22K | +13.6% | pending | — |
| 3/9/2026 | ENOV | $71K | -4.0% | -19.0% | +12.9% |
| 2/27/2026 | ENOV | $75K | -10.9% | -2.2% | +12.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ENOV | ▲ Buy | Open Market | 2,660 | $50K | 9/4/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 5,140 | $100K | 9/3/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 2,458 | $50K | 9/2/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $21K | 6/15/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 200 | $4K | 6/11/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $22K | 6/11/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $23K | 6/10/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $22K | 6/1/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $24K | 3/13/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $24K | 3/10/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $23K | 3/9/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 250 | $6K | 3/6/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 500 | $12K | 3/6/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 250 | $6K | 3/4/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $25K | 3/3/2026 | View on chart |
| ENOV | ▲ Buy | Open Market | 1,000 | $26K | 2/27/2026 | View on chart |
| ENOV | ▲ Buy | Grant | 42,640 | $0 | 1/5/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Enovis joins AAOS Registry Program as industry sponsor
Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.
Enovis joins AAOS Registry Program as industry sponsor. Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.